Fig. 5: CDK9 suppresses RARα protein expression and physically interacts with RARα. | Nature Communications

Fig. 5: CDK9 suppresses RARα protein expression and physically interacts with RARα.

From: CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma

Fig. 5

a Quantitative proteomic analysis and volcano plot of Hut78 cell proteins upon 23 (GT-02897) treatment, with P values derived from Wilcoxon rank-sum test. b Western blotting of indicated proteins in Hut78 under 23 (GT-02897) treatment. Western blot analysis of indicated proteins in HH and Hut78 (c) or 293T (d) cells after CDK9 depletion via lentiviruses. e A doxycycline (Dox)-inducible knockdown system was applied in HH and Hut78 cells, followed by Western blotting post Dox treatment. f Volcano plot revealing differentially expressed genes in Hut78 post CDK9 depletion, with P values derived by Wilcoxon rank-sum test. g Q-PCR assessment of CDK9 and RARA levels in Hut78 cells after CDK9 depletion. h Western blot analysis of proteins in Hut78 after CDK9 depletion, with or without MG132 treatment. i 293T cells were co-transfected with RARα and CDK9 constructs, followed by co-immunoprecipitation (Co-IP) and Western blot analysis. j GST-tagged CDK9 was incubated with HA-RARα from the WCL of 293T cellsĀ transfected with 3 × HA-tagged RARα, followed by GST pulldown and Western blot analysis. WCL: whole cell lysate. k Schematic diagram of full-length CDK9 protein (top). GST pulldown assay was performed using GST-tagged CDK9 and WCL of 293T cells transfected with 3 × HA-tagged RARα. l Lentiviral infection of Hut78 with shNC or shCDK9-1, followed by transfection of EV, 3 × Flag-tagged WT, T186A, and S347A CDK9, and Western blotting of indicated proteins. m Western blotting of indicated proteins in Hut78 post CDK9 depletion or Flavopiridol treatment. n Q-PCR analysis of RARA in Hut78 cells treated with Flavopiridol. o Schematic diagram of full-length RARα protein (top). Co-transfection of 3ƗFlag-tagged CDK9 with full-length or mutant RARα constructs in 293T, followed by Co-IP and immunoblotting (bottom). Results in (g, n) represent biologically independent experiments of n = 3, with P values calculated by two-tailed Student’s t-test. Data are presented as mean ± SEM, with source data provided as a Source Data file. b–e, h–m, o n = 3, independent experiments, a representative example is shown. The samples derive from the same experiment each but different gels for CDK9, β-actin and another for RARα (b, d, e, h), for RARα, β-actin and another for CDK9 (c), for HA-RARα, β-actin and another for Flag-CDK9 (i), for RARα, β-actin and another for Flag-CDK9 (l) were processed in parallel. Band intensities in (b–e, h, l, m) were analyzed and compared using Image J. Relative densitometric values are provided below the blot images.

Back to article page